Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity.

Commun Med (Lond) · 2025 · PMC12316913 · PMID 40750822

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When compared to Phentermine/Topiramate, Tirzepatide showed a lower cataract incidence (HR 0.76; 95% CI: 0.38–1.52; p = 0.433), though this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.